SEROPHENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Serophene, and what generic alternatives are available?
Serophene is a drug marketed by Emd Serono and is included in one NDA.
The generic ingredient in SEROPHENE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Serophene
A generic version of SEROPHENE was approved as clomiphene citrate by COSETTE on August 30th, 1999.
Summary for SEROPHENE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Clinical Trials: | 6 |
| Patent Applications: | 72 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SEROPHENE at DailyMed |
Recent Clinical Trials for SEROPHENE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Illinois at Chicago | Phase 1 |
| Johns Hopkins University | Phase 1 |
| Yale University | Phase 1 |
US Patents and Regulatory Information for SEROPHENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono | SEROPHENE | clomiphene citrate | TABLET;ORAL | 018361-001 | Mar 22, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
